Targacept, Inc. (TRGT) Announces Participation in Upcoming Conferences  
4/23/2013 6:35:24 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the following conferences:

•12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, New York on Tuesday, April 30, 2013 at 12:10 p.m. Eastern Time.

Help employers find you! Check out all the jobs and post your resume.